Sam Razavi

Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials

Jeffrey S. Heier, Eleonora M. Lad, Frank G. Holz et al. · The Lancet · 2023 · 372 citations

Ocular Disease, Ophthalmology, Age-related Diseases +4

Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial

Arshad M. Khanani, Sunil Patel, Giovanni Staurenghi et al. · The Lancet · 2023 · 263 citations · Full text

Clinical Epidemiology, Clinical Trials, Geographic Atrophy +5

Assessment of Choroidal Topographic Changes by Swept-Source Optical Coherence Tomography After Intravitreal Ranibizumab for Exudative Age-Related Macular Degeneration

Sam Razavi, Eric H. Souied, Fatemeh Darvizeh et al. · American Journal of Ophthalmology · 2015 · 42 citations

Ocular Disease, Ophthalmology, Age-related Diseases +6

Assessment of Choroidal Topographic Changes by Swept Source Optical Coherence Tomography After Photodynamic Therapy for Central Serous Chorioretinopathy

Sam Razavi, Eric H. Souied, Edoardo Cavallero et al. · American Journal of Ophthalmology · 2014 · 37 citations

Engineering, Medical Imaging, Ophthalmology +8

Costly gains: a cost–benefit assessment of Iran’s nuclear program

Thomas Juneau, Sam Razavi · The Nonproliferation Review · 2018 · 16 citations

Engineering, Policy Analysis, Nuclear Program +21